| Sonstiges: |
- Nachgewiesen in: MEDLINE
- Sprachen: English
- Publication Type: Journal Article; Research Support, Non-U.S. Gov't
- Language: English
- [Chem Biol Drug Des] 2024 May; Vol. 103 (5), pp. e14531.
- MeSH Terms: Breast Neoplasms* / metabolism ; Breast Neoplasms* / pathology ; Breast Neoplasms* / drug therapy ; Breast Neoplasms* / prevention & control ; Hypoxia-Inducible Factor-Proline Dioxygenases* / metabolism ; Hypoxia-Inducible Factor-Proline Dioxygenases* / antagonists & inhibitors ; Apoptosis* / drug effects ; Humans ; Female ; Animals ; Mice ; Cell Hypoxia / drug effects ; Molecular Docking Simulation ; Antineoplastic Agents / pharmacology ; Antineoplastic Agents / chemistry ; MCF-7 Cells ; Cell Line, Tumor ; NF-kappa B / metabolism ; Tirapazamine / pharmacology ; Tirapazamine / chemistry ; Tirapazamine / metabolism
- References: Adams, S. C., Schondorf, R., Benoit, J., & Kilgour, R. D. (2015). Impact of cancer and chemotherapy on autonomic nervous system function and cardiovascular reactivity in young adults with cancer: A case‐controlled feasibility study. BMC Cancer, 15, 1–13. https://doi.org/10.1186/s12885‐015‐1418‐3. ; Akram, M., Iqbal, M., Daniyal, M., & Khan, A. U. (2017). Awareness and current knowledge of breast cancer. Biological Research, 50, 1–23. https://doi.org/10.1186/s40659‐017‐0140‐9. ; Altman, B. J., Stine, Z. E., & Dang, C. V. (2017). From Krebs to clinic: Glutamine metabolism to cancer therapy. Nature Reviews Cancer, 16, 619–634. https://doi.org/10.1038/nrc.2016.71. ; Berra, E., Benizri, E., Ginouvès, A., Volmat, V., Roux, D., & Pouysségur, J. (2003). HIF prolyl‐hydroxylase 2 is the key oxygen sensor setting low steady‐state levels of HIF‐1α in normoxia. The EMBO Journal, 22, 4082–4090. https://doi.org/10.1093/emboj/cdg392. ; Bordoli, M. R., Stiehl, D. P., Borsig, L., Kristiansen, G., Hausladen, S., Schraml, P., Wenger, R. H., & Camenisch, G. (2011). Prolyl‐4‐hydroxylase PHD2‐ and hypoxia‐inducible factor 2‐dependent regulation of amphiregulin contributes to breast tumorigenesis. Oncogene, 30, 548–560. https://doi.org/10.1038/onc.2010.433. ; Chan, D. A., Kawahara, T. L. A., Sutphin, P. D., Chang, H. Y., Chi, J. T., & Giaccia, A. J. (2009). Tumor vasculature is regulated by PHD2‐mediated angiogenesis and bone marrow‐derived cell recruitment. Cancer Cell, 15, 527–538. https://doi.org/10.1016/j.ccr.2009.04.010. ; Chaturvedi, M. M., Sung, B., Yadav, V. R., Kannappan, R., & Aggarwal, B. B. (2011). NF‐κB addiction and its role in cancer: One size does not fit all. Oncogene, 30, 1615–1630. https://doi.org/10.1038/onc.2010.566. ; Choi, H. J., Song, B. J., Gong, Y. D., Gwak, W. J., & Soh, Y. (2008). Rapid degradation of hypoxia‐inducible factor‐1α by KRH102053, a new activator of prolyl hydroxylase 2. British Journal of Pharmacology, 154, 114–125. https://doi.org/10.1038/bjp.2008.70. ; Cummins, E. P., Berra, E., Comerford, K. M., Ginouves, A., Fitzgerald, K. T., Seeballuck, F., Godson, C., Nielsen, J. E., Moynagh, P., Pouyssegur, J., & Taylor, C. T. (2006). Prolyl hydroxylase‐1 negatively regulates IκB kinase‐β, giving insight into hypoxia‐induced NFκB activity. Proceedings of the National Academy of Sciences of the United States of America, 103, 18154–18159. https://doi.org/10.1073/pnas.0602235103. ; de Saedeleer, C. J., Copetti, T., Porporato, P. E., Verrax, J., Feron, O., & Sonveaux, P. (2012). Lactate activates HIF‐1 in oxidative but not in Warburg‐phenotype human tumor cells. PLoS One, 7, e46571. https://doi.org/10.1371/journal.pone.0046571. ; Devi, U., Singh, M., Roy, S., Tripathi, A. C., Gupta, P. S., Saraf, S. K., Ansari, M. N., Saeedan, A. S., & Kaithwas, G. (2019). PHD‐2 activation: A novel strategy to control HIF‐1α and mitochondrial stress to modulate mammary gland pathophysiology in ER+ subtype. Naunyn‐Schmiedeberg's Archives of Pharmacology, 392, 1239–1256. https://doi.org/10.1007/s00210‐019‐01658‐7. ; Duan, W., Shen, X., Lei, J., Xu, Q., Yu, Y., Li, R., Wu, E., & Ma, Q. (2014). Hyperglycemia, a neglected factor during cancer progression. BioMed Research International, 2014, 461917. https://doi.org/10.1155/2014/461917. ; Eng, C. H., Yu, K., Lucas, J., White, E., & Abraham, R. T. (2010). Ammonia derived from glutaminolysis is a diffusible regulator of autophagy. Science Signaling, 3, 119. https://doi.org/10.1126/SCISIGNAL.2000911. ; Flamant, L., Notte, A., Ninane, N., Raes, M., & Michiels, C. (2010). Anti‐apoptotic role of HIF‐1 and AP‐1 in paclitaxel exposed breast cancer cells under hypoxia. Molecular Cancer, 9, 1–15. https://doi.org/10.1186/1476‐4598‐9‐191. ; Gao, J., Guo, Z., Cheng, J., Sun, B., Yang, J., Li, H., Wu, S., Dong, F., & Yan, X. (2020). Differential metabolic responses in breast cancer cell lines to acidosis and lactic acidosis revealed by stable isotope assisted metabolomics. Scientific Reports, 1–12, 21967. https://doi.org/10.1038/s41598‐020‐78955‐2. ; Kaltschmidt, B., Greiner, J. F. W., Kadhim, H. M., & Kaltschmidt, C. (2018). Subunit‐specific role of NF‐κB in cancer. Biomedicine, 6, 1–12. https://doi.org/10.3390/biomedicines6020044. ; Kumar, S., Ahmed, F., Sonkar, A. A., Saroj, J. K., Parihaar, A., Singhai, A., & Singh, V. K. (2016). Evaluation of serum of breast cancer patients using high resolution magic angle proton magnetic resonance spectroscopy (HR‐MAS): A search for possible biomarker? European Journal of Cancer, 12, 151–155. https://doi.org/10.7438/1584‐9341‐12‐4‐4. ; Kumar, U., Kumar, A., Singh, S., Arya, P., Singh, S. K., Chaurasia, R. N., Singh, A., & Kumar, D. (2021). An elaborative NMR based plasma metabolomics study revealed metabolic derangements in patients with mild cognitive impairment: A study on north Indian population. Metabolic Brain Disease, 36, 957–968. https://doi.org/10.1007/s11011‐021‐00700‐z. ; Kumar, U., Mehta, P., Kumar, S., Jain, A., Guleria, A., Kumar R, V., Misra, R., & Kumar, D. (2021). Circulatory histidine levels as predictive indicators of disease activity in takayasu arteritis. Analytical Science Advances, 2, 527–535. https://doi.org/10.1002/ansa.202000181. ; Kurebayashi, J., Otsuki, T., Moriya, T., & Sonoo, H. (2001). Hypoxia reduces hormone responsiveness of human breast cancer cells. Japanese Journal of Cancer Research, 92, 1093–1101. https://doi.org/10.1111/j.1349‐7006.2001.tb01064.x. ; Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680–685. https://doi.org/10.1038/227680A0. ; Laka, K., Makgoo, L., & Mbita, Z. (2019). Survivin splice variants in arsenic trioxide (As2O3)‐induced deactivation of PI3K and MAPK cell signalling pathways in MCF‐7 cells. Genes (Basel), 10, 1–22. https://doi.org/10.3390/genes10010041. ; Li, L., Zhang, Y., Qiao, J., Yang, J. J., & Liu, Z. R. (2014). Pyruvate kinase M2 in blood circulation facilitates tumor growth by promoting. Angiogenesis, 289, 25812–25821. https://doi.org/10.1074/jbc.M114.576934. ; Liao, X. H., Lu, D. L., Wang, N., Liu, L. Y., Wang, Y., Li, Y. Q., Yan, T. B., Sun, X. G., Hu, P., & Zhang, T. C. (2014). Estrogen receptor α mediates proliferation of breast cancer MCF–7 cells via a p21/PCNA/E2F1‐dependent pathway. The FEBS Journal, 281, 927–942. https://doi.org/10.1111/FEBS.12658. ; Lugano, R., Ramachandran, M., & Dimberg, A. (2020). Tumor angiogenesis: Causes, consequences, challenges and opportunities. Cellular and Molecular Life Sciences, 77, 1745–1770. https://doi.org/10.1007/s00018‐019‐03351‐7. ; Masoud, G. N., & Li, W. (2015). HIF‐1α pathway: Role, regulation and intervention for cancer therapy. Acta Pharmaceutica Sinica B, 5, 378–389. https://doi.org/10.1016/j.apsb.2015.05.007. ; Masson, N., Willam, C., Maxwell, P. H., Pugh, C. W., & Ratcliffe, P. J. (2001). Independent function of two destruction domains in hypoxia‐inducible factor‐α chains activated by prolyl hydroxylation. The EMBO Journal, 20, 5197–5206. https://doi.org/10.1093/emboj/20.18.5197. ; Nepal, M., Gong, Y. D., Park, Y. R., & Soh, Y. (2011). An activator of PHD2, KRH102140, decreases angiogenesis via inhibition of HIF‐1α. Cell Biochemistry and Function, 29, 126–134. https://doi.org/10.1002/cbf.1732. ; Prasad, R., & Koch, B. (2016). In vitro anticancer activities of ethanolic extracts of dendrobium crepidatum and Dendrobium chrysanthum against T‐cell lymphoma. Journal of Cytology and Histology, 7, 1000432. https://doi.org/10.4172/2157‐7099.1000432. ; Qiu, J., Zheng, Q., & Meng, X. (2021). Hyperglycemia and chemoresistance in breast cancer: From cellular mechanisms to treatment response. Frontiers in Oncology, 11, 628359. https://doi.org/10.3389/fonc.2021.628359. ; Rani, A., Roy, S., Singh, M., Devi, U., Yadav, R. K., Gautam, S., Rawat, J. K., Ansari, M. N., Saeedan, A. S., Prakash, A., & Kaithwas, G. (2016). α‐chymotrypsin regulates free fatty acids and UCHL‐1 to ameliorate N‐methyl nitrosourea induced mammary gland carcinoma in albino wistar rats. Inflammopharmacology, 24, 277–286. https://doi.org/10.1007/S10787‐016‐0280‐5/FIGURES/3. ; Rawat, J. K., Roy, S., Singh, M., Guatam, S., Yadav, R. K., Ansari, M. N., Aldossary, S. A., Saeedan, A. S., & Kaithwas, G. (2019). Transcutaneous vagus nerve stimulation regulates the cholinergic anti‐inflammatory pathway to counteract 1, 2‐dimethylhydrazine induced colon carcinogenesis in albino wistar rats. Frontiers in Pharmacology, 10, 1–13. https://doi.org/10.3389/fphar.2019.00353. ; Roy, S., Rawat, A. K., Sammi, S. R., Devi, U., Singh, M., Gautam, S., Yadav, R. K., Rawat, J. K., Singh, L., Ansari, M. N., Saeedan, A. S., Pandey, R., Kumar, D., & Kaithwas, G. (2017). Alpha‐linolenic acid stabilizes HIF‐1α; and downregulates FASN to promote mitochondrial apoptosis for mammary gland chemoprevention. Oncotarget, 8, 70049–70071. https://doi.org/10.18632/ONCOTARGET.19551. ; Roy, S., Singh, M., Rawat, A., Devi, U., Gautam, S., Yadav, R. K., Rawat, J. K., Ansari, M. N., Saeedan, A. S., Kumar, D., & Kaithwas, G. (2018). GLA supplementation regulates PHD2 mediated hypoxia and mitochondrial apoptosis in DMBA induced mammary gland carcinoma. The International Journal of Biochemistry & Cell Biology, 96, 51–62. https://doi.org/10.1016/j.biocel.2018.01.011. ; Rundqvist, H., & Johnson, R. S. (2013). Tumour oxygenation: Implications for breast cancer prognosis. Journal of Internal Medicine, 274, 105–112. https://doi.org/10.1111/joim.12091. ; Ryan, H. E., Poloni, M., McNulty, W., Elson, D., Gassmann, M., Arbeit, J. M., & Johnson, R. S. (2000). Hypoxia‐inducible factor‐1α is a positive factor in solid tumor growth. Cancer Research, 60, 4010–4015. ; Sammi, S. R., Rawat, J. K., Raghav, N., Kumar, A., Roy, S., Singh, M., Gautam, S., Yadav, R. K., Devi, U., Pandey, R., & Kaithwas, G. (2018). Galantamine attenuates N,N‐dimethyl hydrazine induced neoplastic colon damage by inhibiting acetylcholinesterase and bimodal regulation of nicotinic cholinergic neurotransmission. European Journal of Pharmacology, 818, 174–183. https://doi.org/10.1016/J.EJPHAR.2017.10.036. ; Schofield, C. J., & Ratcliffe, P. J. (2004). Oxygen sensing by HIF hydroxylases. Nature Reviews. Molecular Cell Biology, 5, 343–354. ; Semenza, G. L. (2016). The hypoxic tumor microenvironment: A driving force for breast cancer progression. Biochimica et Biophysica Acta, Molecular Cell Research, 1863, 382–391. https://doi.org/10.1016/j.bbamcr.2015.05.036. ; Siegel, R. L., Miller, K. D., & Jemal, A. (2020). Cancer statistics, 2020. CA: A Cancer Journal for Clinicians, 70, 7–30. https://doi.org/10.3322/caac.21590. ; Singh, L., Roy, S., Kumar, A., Rastogi, S., Kumar, D., Ansari, M. N., Saeedan, A. S., Singh, M., & Kaithwas, G. (2021). Repurposing combination therapy of Voacamine with vincristine for downregulation of hypoxia‐inducible factor‐1α/fatty acid synthase co‐axis and prolyl hydroxylase‐2 activation in ER+ mammary neoplasia. Frontiers in Cell and Development Biology, 9, 736910. https://doi.org/10.3389/FCELL.2021.736910. ; Singh, M., Devi, U., Roy, S., Gupta, P. S., & Kaithwas, G. (2018). Chemical activation of prolyl hydroxylase‐2 by BBAP‐1 down regulates hypoxia inducible factor‐1α and fatty acid synthase for mammary gland chemoprevention. RSC Advances, 8, 12848–12860. https://doi.org/10.1039/c8ra01239c. ; Sivandzade, F., Bhalerao, A., & Cucullo, L. (2019). Analysis of the mitochondrial membrane potential using the cationic JC‐1 dye as a sensitive fluorescent probe. Bio‐Protocol, 9, 1–13. https://doi.org/10.21769/bioprotoc.3128. ; Stoner, M., Saville, B., Wormke, M., Dean, D., Burghardt, R., & Safe, S. (2002). Hypoxia induces proteasome‐dependent degradation of estrogen receptor α in ZR‐75 breast cancer cells. Molecular Endocrinology, 16, 2231–2242. https://doi.org/10.1210/me.2001‐0347. ; Su, Y., Loos, M., Giese, N., Metzen, E., Büchler, M. W., Friess, H., Kornberg, A., & Büchler, P. (2012). Prolyl hydroxylase‐2 (PHD2) exerts tumor‐suppressive activity in pancreatic cancer. Cancer, 118, 960–972. https://doi.org/10.1002/cncr.26344. ; Temes, E., Martín‐Puig, S., Acosta‐Iborra, B., Castellanos, M. C., Feijoo‐Cuaresma, M., Olmos, G., Aragonés, J., & Landazuri, M. O. (2005). Activation of HIF‐prolyl hydroxylases by R59949, an inhibitor of the diacylglycerol kinase. The Journal of Biological Chemistry, 280, 24238–24244. https://doi.org/10.1074/jbc.M414694200. ; Towbin, H., Staehelin, T., & Gordon, J. (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proceedings of the National Academy of Sciences of the United States of America, 76, 4350–4354. https://doi.org/10.1073/PNAS.76.9.4350. ; Végran, F., Boidot, R., Michiels, C., Sonveaux, P., & Feron, O. (2011). Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF‐kB/IL‐8 pathway that drives tumor angiogenesis. Cancer Research, 71, 2550–2560. https://doi.org/10.1158/0008‐5472.CAN‐10‐2828. ; Wang, L., Niu, Z., Wang, X., Li, Z., Liu, Y., Luo, F., & Yan, X. (2020). PHD2 exerts anti‐cancer and anti‐inflammatory effects in colon cancer xenografts mice via attenuating NF‐κB activity. Life Sciences, 242, 117167. https://doi.org/10.1016/j.lfs.2019.117167. ; Wang, Z., & Zhang, X. (2017). Chemopreventive activity of honokiol against 7, 12 ‐ dimethylbenz[a]anthracene‐induced mammary cancer in female Sprague Dawley rats. Frontiers in Pharmacology, 8, 1–11. https://doi.org/10.3389/fphar.2017.00320. ; Wong, R. S. Y. (2011). Apoptosis in cancer: From pathogenesis to treatment. Journal of Experimental & Clinical Cancer Research, 30, 87. https://doi.org/10.1186/1756‐9966‐30‐87. ; Wu, J., Huang, T., Hsieh, Y., Wang, Y. F., Yen, C. C., Lee, G. L., Yeh, C. C., Peng, Y. J., Kuo, Y. Y., Wen, H. T., Lin, H. C., Hsiao, C. W., Wu, K. K., Kung, H. J., Hsu, Y. J., & Kuo, C. C. (2020). Cancer‐derived succinate promotes macrophage polarization and cancer metastasis via succinate article cancer‐derived succinate promotes macrophage polarization and cancer metastasis via succinate receptor. Molecular Cell, 77, 213–227.e5. https://doi.org/10.1016/j.molcel.2019.10.023. ; Zhang, L., & Bu, P. (2022). The two sides of creatine in cancer. Trends in Cell Biology, 32, 380–390. https://doi.org/10.1016/J.TCB.2021.11.004. ; Zhang, L., Zhu, Z., Yan, H., Wang, W., Wu, Z., Zhang, F., Zhang, Q., Shi, G., du, J., Cai, H., Zhang, X., Hsu, D., Gao, P., Piao, H. L., Chen, G., & Bu, P. (2021). Article creatine promotes cancer metastasis through creatine promotes cancer metastasis through activation of Smad2/3. Cell Metabolism, 33, 1111–1123.e4. https://doi.org/10.1016/j.cmet.2021.03.009.
- Contributed Indexing: Keywords: DMBA; ER‐positive; PHD‐2 activator; breast cancer; hypoxia
- Substance Nomenclature: EC 1.14.11.29 (Hypoxia-Inducible Factor-Proline Dioxygenases) ; 0 (Antineoplastic Agents) ; EC 1.14.11.2 (EGLN1 protein, human) ; 0 (NF-kappa B) ; 1UD32YR59G (Tirapazamine)
- Entry Date(s): Date Created: 20240510 Date Completed: 20240510 Latest Revision: 20240510
- Update Code: 20240510
|
